Stevens L M, Davis P L, Mueller T. "一种的合成方法" [P]. US Patent, US 10677297 B2, 2021-03-12.
Brown S R, Davis P L, Chen K W. "Method for the Synthesis of 3-Hydroxy-5-methyl-3-(2-oxopropyl)indolin-2-one" [P]. US Patent, US 11066611 B2, 2017-07-25.
发明人朱建伟,周伟,杨光. "A Process for Preparing High-Purity 3-Hydroxy-5-methyl-3-(2-oxopropyl)indolin-2-one" [P]. 中国发明专利, 专利号 CN 113967825 B, 授权公告日 2022-03-28.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2022, 2166, (7), 4031-4036.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2015, 2155, (11), 8424-8431.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 3-Hydroxy-5-methyl-3-(2-oxopropyl)indolin-2-one Using HRMS and NMR". Biomed. Chromatogr., 2025, 413, (12), 2288-2306.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2013, 1100, 3165-3170.